{
    "code": "02026065",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02026065",
    "time": "2016-11-18 20:47:33",
    "許可證字號": "衛署藥輸字第026065號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/06\/07",
    "發證日期": "102\/06\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202606501",
    "中文品名": "健米喜凍晶注射劑",
    "英文品名": "Gemcitabine Teva Powder for Solution for Infusion",
    "適應症": "非小細胞肺癌、胰臟癌、膀胱癌。Gemcitabine與paclitaxel併用，可使用於曾經使用過Anthracycline之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑類藥物（Platinum-Based）治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。",
    "劑型": "243凍晶注射劑",
    "包裝": "200毫克，1公克，2公克小瓶 各100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "GEMCITABINEHYDROCHLORIDE"
    ],
    "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
    "申請商名稱": "620102K944  香港商艾維斯有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F170029100  PHARMACHEMIE B.V.",
        "製造廠廠址": "SWENSWEG 5,2031 GA HAARLEM,THE NETHERLANDS",
        "製造廠公司地址": "P.O.BOX 552, 2003 RN HAARLEM,THE NETHERLANDS",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(eq. to Gemcitabine 200mg)",
            "含量": "227.7000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(eq. to Gemcitabine 1000mg)",
            "含量": "1138.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "eq. to Gemcitabine 2000mg)",
            "含量": "2277.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020260650001-PI-104-10-27(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026065&Seq=002&Type=9"
        },
        {
            "title": "020260650001-102-09-17.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026065&Seq=001&Type=9"
        },
        {
            "title": "020260650004-2000mg carton label-104-10-27(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026065&Seq=006&Type=8"
        },
        {
            "title": "020260650003-1000mg carton label-104-10-27(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026065&Seq=005&Type=8"
        },
        {
            "title": "020260650002-200mg carton label-104-10-27(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026065&Seq=004&Type=8"
        },
        {
            "title": "020260650004-102-09-17.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026065&Seq=003&Type=8"
        },
        {
            "title": "020260650003-102-09-17.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026065&Seq=002&Type=8"
        },
        {
            "title": "020260650002-102-09-17.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026065&Seq=001&Type=8"
        }
    ]
}